| Literature DB >> 29955687 |
Emmanuelle T Torchon1, Suchita Das1, Ronique C Beckford1, Brynn H Voy1.
Abstract
Epidemiologic studies associate perinatal intake of eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) with reduced adiposity in children, suggesting that these fatty acids may alter adipose tissue development. The objective of this study was to determine whether enriching the perinatal diet in EPA and DHA reduces fat deposition in young chicks. Cobb 500 broiler chicks were fed isocaloric diets containing fat (8% wt:wt) from fish oil (FO), lard, canola oil, or flaxseed oil from 7 to 30 d of age. Adiposity (abdominal fat pad weight/body weight) at 30 d was not significantly affected by diet, but FO significantly reduced adipocyte size, increasing the abundance of small adipocytes. Plasma nonesterified fatty acid concentrations suggest that reduced adipocyte size was due, in part, to enhanced mobilization of fatty acids from adipose tissue. Our work indicates that dietary EPA and DHA effectively reduce the size of developing adipocytes in juveniles, which may limit adipose deposition and provide metabolic benefits.Entities:
Keywords: adipose tissue; childhood obesity; fatty acids; model organism; obesity
Year: 2017 PMID: 29955687 PMCID: PMC5998788 DOI: 10.3945/cdn.117.001644
Source DB: PubMed Journal: Curr Dev Nutr ISSN: 2475-2991
Effects of dietary LA, CA, FL, and FO on body, adipose, and muscle weights and on serum metabolites in broiler chicks
| LA | CA | FL | FO |
| |
|---|---|---|---|---|---|
| Body weight, g | 1752 ± 46.7b | 1650 ± 54.6a,b | 1694 ± 45.1a,b | 1562 ± 45.0a | 0.045 |
| Breast weight, g | 337.9 ± 13.8 | 360.2 ± 16.5 | 354.6 ± 13.6 | 346.1 ± 7.9 | 0.573 |
| Relative breast weight, | 19.4 ± 1.0 | 21.9 ± 0.6 | 21.0 ± 1.0 | 22.1 ± 1.7 | 0.400 |
| Adipose tissue weight, g | 26.0 ± 1.9 | 24.5 ± 1.2 | 22.3 ± 1.2 | 24.3 ± 1.8 | 0.455 |
| Relative adipose weight, | 1.48 ± 0.09 | 1.51 ± 0.07 | 1.33 ± 0.07 | 1.56 ± 0.12 | 0.499 |
| NEFAs, mM | 6.25 ± 1.98b | 6.49 ± 0.79b | 6.55 ± 1.41b | 10.04 ± 0.96a | 0.002 |
| Glucose, mg/dL | 175.7 ± 12.8 | 184.5 ± 10.8 | 189.4 ± 7.0 | 168.1 ± 5.7 | 0.130 |
| Adipocyte volume, μm | 3651 ± 420.7a | 3706 ± 184.1a | 3098 ± 95.2ab | 2546 ± 153.1b | 0.020 |
| Adipocyte number | 75.4 ± 13.3 | 70.8 ± 9.5 | 93.7 ± 9.8 | 90.3 ± 8.1 | 0.093 |
Values are means ± SEMs for all chicks in each diet group, n = 10/group. Means with shared superscript letters do not differ significantly, P < 0.05. CA, canola oil; FL, flaxseed oil; FO, fish oil; LA, lard.
Derived by using single-factor ANOVA for effect of diet.
[Breast weight (g)/body weight (g)] × 100.
[Abdominal adipose depot weight (g)/body weight (g)] × 100.
Calculated from adipocyte volume and adipose depot weight.
FIGURE 1Effects of dietary FO, FL, CA, and LA on abdominal adipocyte size distribution and on gene expression in liver and adipose tissue. (A) Adipocyte area was measured from images of hematoxylin-and-eosin–stained sections of abdominal adipose tissue () by using ImageJ (version 1.48; NIH); areas <500 μm2 were removed from analyses. Adipocyte volume (μm3) was calculated from area (μm2). Frequency distributions were produced by grouping adipocytes into bins on the basis of volume and counting the frequency of cells within each bin. ANOVA was used to evaluate the effect of diet within each bin. (B and C) Relative mRNA expression of genes involved in lipid metabolism, adipogenesis, and inflammation in abdominal adipose tissue (B) and in lipid metabolism in liver (C); n = 6 birds/diet. Values are group means ± group SDs. Means without a common lowercase letter differ significantly (P < 0.05) based on post hoc testing when ANOVA indicated a significant effect of diet (P < 0.05). ACOX1, acyl-CoA oxidase 1; CA, canola oil; CCL20, chemokine C-C ligand 20; CPT1α, carnitine palmitoyl acyltransferase 1α CSF1R, colony stimulating factor 1 receptor; EGR1, early growth response transcription factor 1; FASN, FA synthase; FL, flaxseed oil; FO, fish oil; LA, lard; LPIN1, lipin-1; LPL, lipoprotein lipase; PCK1, phosphoenolpyruvate carboxykinase 1; PDK4, pyruvate dehydrogenase kinase 4; PNPLA8, patatin-like phospholipase domain containing protein 8; PPARG, PPAR-γ PPARGC1B, PPARG coactivator 1 beta.